Protagonist Therapeutics (PTGX) Tax Provisions (2018 - 2026)
Protagonist Therapeutics (PTGX) posted Tax Provisions of -$1.5 million for Q1 2026, down 325.53% sequentially from $666000.0 in Q4 2025.
Protagonist Therapeutics (PTGX) Tax Provisions (2018 - 2026) Analysis & Trends
Protagonist Therapeutics has reported Tax Provisions for 7 years, with the latest figure at -$1.5 million in Q1 2026.
- Quarterly Tax Provisions changed N/A year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$636000.0 (down 170.67% YoY) and the FY2025 annual result came in at $838000.0, down 80.14% from the prior year.
- Tax Provisions declined to -$1.5 million in Q1 2026 per PTGX's latest filing, from $666000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $3.3 million in Q1 2024 and troughed at -$16.6 million in Q4 2023.
- A 4-year average of -$1.6 million and a median of -$110000.0 in 2024 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 128.57% in 2025, down 67.03% in 2025.
- Over 4 years, Tax Provisions stood at -$16.6 million in 2023, then jumped by 112.18% to $2.0 million in 2024, then slumped by 67.03% to $666000.0 in 2025, then slumped by 325.53% to -$1.5 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$1.5 million, $666000.0, and $200000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30 Mn |
| Mar 31, 2026 | -1.50 Mn |
| Dec 31, 2025 | 666,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | -420,000.00 |
| Jun 30, 2024 | -700,000.00 |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | -16.58 Mn |
| Jun 30, 2020 | 1.10 Mn |
| Mar 31, 2020 | 176,000.00 |
| Dec 31, 2019 | 856,000.00 |
| Sep 30, 2019 | -100,000.00 |
| Jun 30, 2019 | -1.10 Mn |
| Mar 31, 2019 | 183,000.00 |
| Dec 31, 2018 | -799,000.00 |